Tianjin Chase Sun Pharmaceutical Co Ltd (300026) — Strategic Asset Allocation Index
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Strategic Asset Allocation Index of 38.0% as of June 2023. Strategic assets (PP&E of CN¥3.31 Billion plus long-term investments of CN¥-) total CN¥3.31 Billion, measured against net assets of CN¥8.72 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 300026 equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Tianjin Chase Sun Pharmaceutical Co Ltd Strategic Asset Allocation Index (2006–2021)
This chart shows how Tianjin Chase Sun Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 16 annual periods from 2006 to 2021. As of June 2023, the index stands at 38.0%, representing strategic assets of CN¥3.31 Billion against net assets of CN¥8.72 Billion CNY. For live market cap and overall valuation, see market cap of Tianjin Chase Sun Pharmaceutical Co Ltd.
Annual Strategic Asset Allocation Index for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2021, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 300026 total equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 36.5% | CN¥2.90 Billion | CN¥2.90 Billion | CN¥- | CN¥7.95 Billion | ▲ +1.9 pp |
| 2020 | 34.6% | CN¥2.56 Billion | CN¥2.56 Billion | CN¥- | CN¥7.39 Billion | ▲ +2.0 pp |
| 2019 | 32.6% | CN¥2.31 Billion | CN¥2.31 Billion | CN¥- | CN¥7.07 Billion | ▲ +0.9 pp |
| 2018 | 31.7% | CN¥2.08 Billion | CN¥1.80 Billion | CN¥281.52 Million | CN¥6.58 Billion | ▲ +3.3 pp |
| 2017 | 28.4% | CN¥1.85 Billion | CN¥1.58 Billion | CN¥273.62 Million | CN¥6.51 Billion | ▲ +1.8 pp |
| 2016 | 26.7% | CN¥1.61 Billion | CN¥1.37 Billion | CN¥235.55 Million | CN¥6.04 Billion | ▲ +4.6 pp |
| 2015 | 22.1% | CN¥1.17 Billion | CN¥1.13 Billion | CN¥43.16 Million | CN¥5.29 Billion | ▼ -9.7 pp |
| 2014 | 31.8% | CN¥749.15 Million | CN¥749.15 Million | CN¥- | CN¥2.36 Billion | ▼ -11.2 pp |
| 2013 | 42.9% | CN¥731.17 Million | CN¥731.17 Million | CN¥- | CN¥1.70 Billion | ▼ -7.7 pp |
| 2012 | 50.6% | CN¥702.07 Million | CN¥702.07 Million | CN¥- | CN¥1.39 Billion | ▲ +13.4 pp |
| 2011 | 37.2% | CN¥390.79 Million | CN¥390.79 Million | CN¥- | CN¥1.05 Billion | ▲ +18.2 pp |
| 2010 | 19.0% | CN¥208.23 Million | CN¥208.23 Million | CN¥- | CN¥1.10 Billion | ▲ +5.9 pp |
| 2009 | 13.0% | CN¥120.89 Million | CN¥120.89 Million | CN¥- | CN¥926.88 Million | ▼ -53.9 pp |
| 2008 | 66.9% | CN¥84.02 Million | CN¥84.02 Million | CN¥- | CN¥125.51 Million | ▼ -7.1 pp |
| 2007 | 74.1% | CN¥45.37 Million | CN¥45.37 Million | CN¥- | CN¥61.24 Million | ▼ -119.6 pp |
| 2006 | 193.7% | CN¥41.21 Million | CN¥41.21 Million | CN¥- | CN¥21.28 Million | — |